Does the media prefer FTLF or IPSC?

In the previous week, Century Therapeutics had 4 more articles in the media than FitLife Brands. MarketBeat recorded 6 mentions for Century Therapeutics and 2 mentions for FitLife Brands. FitLife Brands' average media sentiment score of 0.93 beat Century Therapeutics' score of 0.26 indicating that FitLife Brands is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FitLife Brands 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Century Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is FTLF or ZURA more profitable?

FitLife Brands has a net margin of 6.64% compared to Zura Bio's net margin of 0.00%. FitLife Brands' return on equity of 18.31% beat Zura Bio's return on equity. Company Net Margins Return on Equity Return on Assets FitLife Brands 6.64% 18.31% 8.21% Zura Bio N/A -55.74% -48.07%

Does the media favor FTLF or ZURA?

In the previous week, FitLife Brands and FitLife Brands both had 2 articles in the media. FitLife Brands' average media sentiment score of 0.93 beat Zura Bio's score of 0.45 indicating that FitLife Brands is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FitLife Brands 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zura Bio 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor STTK or FTLF?

In the previous week, Shattuck Labs had 18 more articles in the media than FitLife Brands. MarketBeat recorded 20 mentions for Shattuck Labs and 2 mentions for FitLife Brands. FitLife Brands' average media sentiment score of 0.93 beat Shattuck Labs' score of 0.52 indicating that FitLife Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shattuck Labs 4 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive FitLife Brands 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, SNDL or FTLF?

FitLife Brands has lower revenue, but higher earnings than SNDL. SNDL is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SNDL $677.32M 0.54 -$11.29M -$0.03 N/A FitLife Brands $81.46M 1.27 $6.33M $0.60 18.35

Is SNDL or FTLF more profitable?

FitLife Brands has a net margin of 6.64% compared to SNDL's net margin of -1.19%. FitLife Brands' return on equity of 18.31% beat SNDL's return on equity. Company Net Margins Return on Equity Return on Assets SNDL -1.19% -1.02% -0.85% FitLife Brands 6.64% 18.31% 8.21%

Does the media prefer SNDL or FTLF?

In the previous week, SNDL and SNDL both had 2 articles in the media. FitLife Brands' average media sentiment score of 0.93 beat SNDL's score of 0.66 indicating that FitLife Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SNDL 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive FitLife Brands 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

FitLife Brands (FTLF) Competitors

$11.01 0.00 (0.00%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$10.76 -0.25 (-2.26%)

As of 06/12/2026 04:33 PM Eastern

Compare

FTLF vs. XFOR, IPSC, ZURA, STTK, and SNDL

Should you buy FitLife Brands stock or one of its competitors? MarketBeat compares FitLife Brands with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with FitLife Brands include X4 Pharmaceuticals (XFOR), Century Therapeutics (IPSC), Zura Bio (ZURA), Shattuck Labs (STTK), and SNDL (SNDL). These companies are all part of the "pharmaceutical products" industry.

How does FitLife Brands compare to X4 Pharmaceuticals?

X4 Pharmaceuticals (NASDAQ:XFOR) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation.

FitLife Brands has a net margin of 6.64% compared to X4 Pharmaceuticals' net margin of -1,106.30%. FitLife Brands' return on equity of 18.31% beat X4 Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
X4 Pharmaceuticals	-1,106.30%	-94.90%	-48.09%
FitLife Brands	6.64%	18.31%	8.21%

In the previous week, FitLife Brands had 1 more articles in the media than X4 Pharmaceuticals. MarketBeat recorded 2 mentions for FitLife Brands and 1 mentions for X4 Pharmaceuticals. X4 Pharmaceuticals' average media sentiment score of 1.87 beat FitLife Brands' score of 0.93 indicating that X4 Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
X4 Pharmaceuticals	Very Positive
FitLife Brands	Positive

72.0% of X4 Pharmaceuticals shares are owned by institutional investors. Comparatively, 2.3% of FitLife Brands shares are owned by institutional investors. 1.1% of X4 Pharmaceuticals shares are owned by company insiders. Comparatively, 61.4% of FitLife Brands shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

FitLife Brands has higher revenue and earnings than X4 Pharmaceuticals. X4 Pharmaceuticals is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
X4 Pharmaceuticals	$35.11M	10.75	-$79.20M	-$4.54	N/A
FitLife Brands	$81.46M	1.27	$6.33M	$0.60	18.35

X4 Pharmaceuticals currently has a consensus price target of $9.38, indicating a potential upside of 134.38%. FitLife Brands has a consensus price target of $21.50, indicating a potential upside of 95.28%. Given X4 Pharmaceuticals' stronger consensus rating and higher probable upside, equities research analysts clearly believe X4 Pharmaceuticals is more favorable than FitLife Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
X4 Pharmaceuticals	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
FitLife Brands	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

X4 Pharmaceuticals has a beta of 0.34, meaning that its stock price is 66% less volatile than the broader market. Comparatively, FitLife Brands has a beta of 0.02, meaning that its stock price is 98% less volatile than the broader market.

Summary

FitLife Brands beats X4 Pharmaceuticals on 9 of the 16 factors compared between the two stocks.

How does FitLife Brands compare to Century Therapeutics?

FitLife Brands (NASDAQ:FTLF) and Century Therapeutics (NASDAQ:IPSC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

FitLife Brands has higher revenue and earnings than Century Therapeutics. Century Therapeutics is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$81.46M	1.27	$6.33M	$0.60	18.35
Century Therapeutics	N/A	N/A	-$9.58M	-$1.14	N/A

2.3% of FitLife Brands shares are owned by institutional investors. Comparatively, 50.2% of Century Therapeutics shares are owned by institutional investors. 61.4% of FitLife Brands shares are owned by company insiders. Comparatively, 2.4% of Century Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

FitLife Brands has a net margin of 6.64% compared to Century Therapeutics' net margin of 0.00%. FitLife Brands' return on equity of 18.31% beat Century Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FitLife Brands	6.64%	18.31%	8.21%
Century Therapeutics	N/A	-49.89%	-37.42%

In the previous week, Century Therapeutics had 4 more articles in the media than FitLife Brands. MarketBeat recorded 6 mentions for Century Therapeutics and 2 mentions for FitLife Brands. FitLife Brands' average media sentiment score of 0.93 beat Century Therapeutics' score of 0.26 indicating that FitLife Brands is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FitLife Brands	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Century Therapeutics	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

FitLife Brands has a beta of 0.02, suggesting that its share price is 98% less volatile than the broader market. Comparatively, Century Therapeutics has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market.

FitLife Brands currently has a consensus price target of $21.50, indicating a potential upside of 95.28%. Century Therapeutics has a consensus price target of $4.75, indicating a potential upside of 111.11%. Given Century Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Century Therapeutics is more favorable than FitLife Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Century Therapeutics	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Summary

FitLife Brands beats Century Therapeutics on 9 of the 15 factors compared between the two stocks.

How does FitLife Brands compare to Zura Bio?

FitLife Brands (NASDAQ:FTLF) and Zura Bio (NASDAQ:ZURA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

In the previous week, FitLife Brands and FitLife Brands both had 2 articles in the media. FitLife Brands' average media sentiment score of 0.93 beat Zura Bio's score of 0.45 indicating that FitLife Brands is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FitLife Brands	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zura Bio	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

FitLife Brands has a beta of 0.02, indicating that its share price is 98% less volatile than the broader market. Comparatively, Zura Bio has a beta of 0.03, indicating that its share price is 97% less volatile than the broader market.

2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 61.1% of Zura Bio shares are held by institutional investors. 61.4% of FitLife Brands shares are held by insiders. Comparatively, 12.4% of Zura Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

FitLife Brands presently has a consensus target price of $21.50, suggesting a potential upside of 95.28%. Zura Bio has a consensus target price of $10.75, suggesting a potential upside of 190.54%. Given Zura Bio's stronger consensus rating and higher probable upside, analysts clearly believe Zura Bio is more favorable than FitLife Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Zura Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

FitLife Brands has higher revenue and earnings than Zura Bio. Zura Bio is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$81.46M	1.27	$6.33M	$0.60	18.35
Zura Bio	N/A	N/A	-$99.35M	-$1.09	N/A

FitLife Brands has a net margin of 6.64% compared to Zura Bio's net margin of 0.00%. FitLife Brands' return on equity of 18.31% beat Zura Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FitLife Brands	6.64%	18.31%	8.21%
Zura Bio	N/A	-55.74%	-48.07%

Summary

FitLife Brands beats Zura Bio on 9 of the 15 factors compared between the two stocks.

How does FitLife Brands compare to Shattuck Labs?

Shattuck Labs (NASDAQ:STTK) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings.

In the previous week, Shattuck Labs had 18 more articles in the media than FitLife Brands. MarketBeat recorded 20 mentions for Shattuck Labs and 2 mentions for FitLife Brands. FitLife Brands' average media sentiment score of 0.93 beat Shattuck Labs' score of 0.52 indicating that FitLife Brands is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shattuck Labs	4 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
FitLife Brands	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

FitLife Brands has a net margin of 6.64% compared to Shattuck Labs' net margin of 0.00%. FitLife Brands' return on equity of 18.31% beat Shattuck Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shattuck Labs	N/A	-60.73%	-55.75%
FitLife Brands	6.64%	18.31%	8.21%

FitLife Brands has higher revenue and earnings than Shattuck Labs. Shattuck Labs is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shattuck Labs	$1M	378.80	-$48.81M	-$0.63	N/A
FitLife Brands	$81.46M	1.27	$6.33M	$0.60	18.35

Shattuck Labs currently has a consensus target price of $11.00, suggesting a potential upside of 122.67%. FitLife Brands has a consensus target price of $21.50, suggesting a potential upside of 95.28%. Given Shattuck Labs' stronger consensus rating and higher possible upside, equities research analysts clearly believe Shattuck Labs is more favorable than FitLife Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shattuck Labs	1 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.80
FitLife Brands	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

58.7% of Shattuck Labs shares are held by institutional investors. Comparatively, 2.3% of FitLife Brands shares are held by institutional investors. 8.8% of Shattuck Labs shares are held by company insiders. Comparatively, 61.4% of FitLife Brands shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Shattuck Labs has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market. Comparatively, FitLife Brands has a beta of 0.02, suggesting that its stock price is 98% less volatile than the broader market.

Summary

FitLife Brands beats Shattuck Labs on 9 of the 16 factors compared between the two stocks.

How does FitLife Brands compare to SNDL?

SNDL (NASDAQ:SNDL) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

2.3% of FitLife Brands shares are owned by institutional investors. 61.4% of FitLife Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

FitLife Brands has a net margin of 6.64% compared to SNDL's net margin of -1.19%. FitLife Brands' return on equity of 18.31% beat SNDL's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-1.19%	-1.02%	-0.85%
FitLife Brands	6.64%	18.31%	8.21%

FitLife Brands has lower revenue, but higher earnings than SNDL. SNDL is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$677.32M	0.54	-$11.29M	-$0.03	N/A
FitLife Brands	$81.46M	1.27	$6.33M	$0.60	18.35

SNDL has a beta of 0.91, suggesting that its share price is 9% less volatile than the broader market. Comparatively, FitLife Brands has a beta of 0.02, suggesting that its share price is 98% less volatile than the broader market.

SNDL currently has a consensus price target of $5.00, indicating a potential upside of 252.11%. FitLife Brands has a consensus price target of $21.50, indicating a potential upside of 95.28%. Given SNDL's higher possible upside, analysts clearly believe SNDL is more favorable than FitLife Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
FitLife Brands	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, SNDL and SNDL both had 2 articles in the media. FitLife Brands' average media sentiment score of 0.93 beat SNDL's score of 0.66 indicating that FitLife Brands is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SNDL	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
FitLife Brands	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

FitLife Brands beats SNDL on 12 of the 15 factors compared between the two stocks.

Get FitLife Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FTLF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FTLF vs. The Competition

Export

Metric	FitLife Brands	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$103.38M	$8.31B	$6.52B	$12.05B
Dividend Yield	N/A	2.50%	2.67%	5.66%
P/E Ratio	18.23	15.64	24.00	24.42
Price / Sales	1.27	7.06	514.36	111.24
Price / Cash	9.44	17.44	27.48	37.92
Price / Book	2.37	3.62	10.54	6.82
Net Income	$6.33M	$224.06M	$3.57B	$337.56M
7 Day Performance	6.17%	-1.40%	0.60%	1.17%
1 Month Performance	4.86%	4.39%	1.56%	3.16%
1 Year Performance	-21.36%	-0.88%	25.42%	30.58%

FitLife Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FTLF FitLife Brands	4.523 of 5 stars	$11.01 flat	$21.50 +95.3%	-21.4%	$103.38M	$81.46M	18.23	20	Gap Up
XFOR X4 Pharmaceuticals	2.8539 of 5 stars	$3.97 -1.7%	$9.38 +136.1%	+41.8%	$374.45M	$35.11M	N/A	80	Positive News
IPSC Century Therapeutics	2.0891 of 5 stars	$2.07 -4.6%	$4.75 +129.5%	+291.0%	$373.34M	N/A	N/A	170
ZURA Zura Bio	2.5632 of 5 stars	$3.86 -5.9%	$10.75 +178.5%	+208.3%	$366.24M	N/A	N/A	3
STTK Shattuck Labs	4.4522 of 5 stars	$4.75 -2.5%	$13.00 +173.7%	+389.1%	$364.23M	$1M	N/A	100	Analyst Upgrade Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FTLF) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FitLife Brands (FTLF) Competitors

FTLF vs. XFOR, IPSC, ZURA, STTK, and SNDL

How does FitLife Brands compare to X4 Pharmaceuticals?

Summary

How does FitLife Brands compare to Century Therapeutics?

Summary

How does FitLife Brands compare to Zura Bio?

Summary

How does FitLife Brands compare to Shattuck Labs?

Summary

How does FitLife Brands compare to SNDL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTLF vs. The Competition

FitLife Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

FitLife Brands (FTLF) Competitors

FTLF vs. XFOR, IPSC, ZURA, STTK, and SNDL

How does FitLife Brands compare to X4 Pharmaceuticals?

Is XFOR or FTLF more profitable?

Does the media prefer XFOR or FTLF?

Do institutionals and insiders believe in XFOR or FTLF?

Which has stronger valuation & earnings, XFOR or FTLF?

Do analysts recommend XFOR or FTLF?

Which has more volatility & risk, XFOR or FTLF?

Summary

How does FitLife Brands compare to Century Therapeutics?

Which has higher earnings and valuation, FTLF or IPSC?

Do institutionals & insiders believe in FTLF or IPSC?

Is FTLF or IPSC more profitable?

Does the media prefer FTLF or IPSC?

Which has more risk and volatility, FTLF or IPSC?

Do analysts recommend FTLF or IPSC?

Summary

How does FitLife Brands compare to Zura Bio?

Does the media favor FTLF or ZURA?

Which has more volatility & risk, FTLF or ZURA?

Do insiders and institutionals have more ownership in FTLF or ZURA?

Do analysts prefer FTLF or ZURA?

Which has higher valuation & earnings, FTLF or ZURA?

Is FTLF or ZURA more profitable?

Summary

How does FitLife Brands compare to Shattuck Labs?

Does the media favor STTK or FTLF?

Is STTK or FTLF more profitable?

Which has higher earnings & valuation, STTK or FTLF?

Do analysts rate STTK or FTLF?

Do insiders & institutionals have more ownership in STTK or FTLF?

Which has more risk & volatility, STTK or FTLF?

Summary

How does FitLife Brands compare to SNDL?

Do institutionals & insiders believe in SNDL or FTLF?

Is SNDL or FTLF more profitable?

Which has higher earnings & valuation, SNDL or FTLF?

Which has more risk and volatility, SNDL or FTLF?

Do analysts recommend SNDL or FTLF?

Does the media prefer SNDL or FTLF?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTLF vs. The Competition

FitLife Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools